Stock News

$0.01 EPS Expected for Semler Scientific, Inc. (SMLR); Cramer Rosenthal Mcglynn Has Lifted By $301,840 Its Boston Private Financial Holdings (BPFH) Stake

Cramer Rosenthal Mcglynn Llc increased Boston Private Financial Holdings Inc (BPFH) stake by 1.38% reported in 2017Q3 SEC filing. Cramer Rosenthal Mcglynn Llc acquired 18,865 shares as Boston Private Financial Holdings Inc (BPFH)’s stock declined 12.65%. The Cramer Rosenthal Mcglynn Llc holds 1.39M shares with $23.02M value, up from 1.37 million last quarter. Boston Private Financial Holdings Inc now has $1.26B valuation. It closed at $14.95 lastly. It is down 23.13% since February 22, 2017 and is uptrending. It has outperformed by 6.43% the S&P500.

Analysts expect Semler Scientific, Inc. (OTCMKTS:SMLR) to report $0.01 EPS on February, 28 before the open.They anticipate $0.05 EPS change or 125.00% from last quarter’s $-0.04 EPS. SMLR’s profit would be $59,028 giving it 187.50 P/E if the $0.01 EPS is correct. After having $-0.01 EPS previously, Semler Scientific, Inc.’s analysts see -200.00% EPS growth. The stock increased 0.13% or $0.01 during the last trading session, reaching $7.5. About shares traded. Semler Scientific, Inc. (OTCMKTS:SMLR) has 0.00% since February 22, 2017 and is . It has underperformed by 16.70% the S&P500.

Semler Scientific, Inc. develops, manufactures, and markets patented products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company has market cap of $44.27 million. The Company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition; and WellChec, a multi-test service platform that performs tests for various chronic diseases, such as respiratory disease, vascular disease, eye disease, bone disease, heart disease, neuropathy, and diabetes. It currently has negative earnings. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as organizations, including healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry; and other healthcare organizations, such as risk assessment groups and other home healthcare providers.

Since January 22, 2018, it had 4 insider purchases, and 4 selling transactions for $483,989 activity. 2,334 Boston Private Financial Holdings, Inc. (NASDAQ:BPFH) shares with value of $36,119 were sold by Wells Donna. 5,500 shares were sold by Waters Stephen M, worth $85,303 on Monday, January 22. Shares for $48,312 were bought by MacDonald W. Timothy. Morton John III also sold $542,092 worth of Boston Private Financial Holdings, Inc. (NASDAQ:BPFH) on Monday, January 22. The insider Higgins Martha sold $222,823. Another trade for 5,000 shares valued at $75,950 was made by Griffin Corey on Tuesday, January 30. 5,700 shares were bought by FURLONG MARK F, worth $86,850.

Cramer Rosenthal Mcglynn Llc decreased Flowers Foods Inc (NYSE:FLO) stake by 978,735 shares to 1.18 million valued at $22.24M in 2017Q3. It also reduced Empire State Realty Trust Inc (NYSE:ESRT) stake by 25,120 shares and now owns 1.23M shares. Cooper Cos Inc/The (NYSE:COO) was reduced too.

Leave a Reply

Your email address will not be published. Required fields are marked *